HIGHLIGHTS
- who: Joanna Forycka and colleagues from the Department of Nephrocardiology, Medical University of Lodz, ulZeromskiego, Lodz, Poland have published the paper: New Insights into the Use of Empagliflozinu2014A Comprehensive Review, in the Journal: Biomedicines 2022, 3294 of 19/Dec/2022
- what: The study focused on changes in HbA1C, patients` body weight and BP, which are strongly associated with the occurrence of albuminuria in patients with T2DM . The study was also concerned with renal parameters, meaning changes in eGFR and UACR. The clinical trial conducted by Zannad et_al , which was based on the EMPERORReduced trial, was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.